Mayne Pharma Group (OTCMKTS:MAYNF) Trading 19.6% Higher – Still a Buy?

Mayne Pharma Group Limited (OTCMKTS:MAYNF) shares rose 19.6% during trading on Tuesday . The stock traded as high as $1.9726 and last traded at $1.9726. Approximately 4,000 shares were traded during trading, an increase of 27% from the average session volume of 3,150 shares. The stock had previously closed at $1.65.

Mayne Pharma Group Stock Up 19.6%

The firm has a 50 day simple moving average of $1.64 and a two-hundred day simple moving average of $1.80.

Mayne Pharma Group Company Profile

Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.

In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.